|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.3 CHF | 0.00% |
|
+1.18% | -31.26% |
| Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Xlife Sciences AG announced Except for the incumbent Chairman, Dr. Bernhard Scholz, who, as planned, will not stand for re-election for the next term of office.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.26% | 214M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
XLIFE SCIENCES AG 
